SARS_CoV_2 mutation literature information.


  Dominant clade-featured SARS-CoV-2 co-occurring mutations reveal plausible epistasis: An in silico based hypothetical model.
 PMID: 34676891       2021       Journal of medical virology
Introduction: GISAID referred to the
Result: Spike protein D614G mutation favors Elastase-2 binding.
Result: The S:p.D614G might assist in rapid entry into the host cells followed by quick dissemination, and the RdRp:p:P323L may instead boost the replication by a faster RNA processing (exiting).


  Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques.
 PMID: 34678071       2021       Science advances
Introduction: Therefore, we studied the pathogenesis of B.1.1.7 and B.1.351 in rhesus macaques and compared it to a recent SARS-CoV-2 isolate containing the D614G substitution in spike that rapidly became dominant globally in March 2020 because of its increased transmissibility.
Result: All the spike proteins of the three isolates:D614G, B.1.1.7, and B.1.351:bound more efficiently to human and rhesus macaque ACE2 than the WA1 spike.
Result: Although B.1.1.7 appears to be detected in the various tissue samples more frequently than D614G and B.1.351, these differences were not statistically significant in individual tissues.


  In Vitro Effect of Taraxacum officinale Leaf Aqueous Extract on the Interaction between ACE2 Cell Surface Receptor and SARS-CoV-2 Spike Protein D614 and Four Mutants.
 PMID: 34681279       2021       Pharmaceuticals (Basel, Switzerland)
Abstract: This could be shown for the wild type and mutant forms (D614G, N501Y, and a mix of K417N, E484K, and N501Y) in human HEK293-hACE2 kidney and A549-hACE2-TMPRSS2 lung cells.
Introduction: Here we report on the inhibitory potential of dandelion on the binding of the spike S1 protein RBD to the hACE2 cell surface receptor an
Discussion: To date, several studies indicate that the D614G viral lineage is more infectious than the D614 virus.


  SARS-CoV-2 Evolution among Oncological Population: In-Depth Virological Analysis of a Clinical Cohort.
 PMID: 34683466       2021       Microorganisms
Discussion: Compared with the Wuhan reference strain, all of the samples sequenced in the present study had a single-nucleotide variation (SNV) at positions 241, 3037, 14408 and 23403, the last one corresponding to the D614G amino acid mutation on the S gene.
Discussion: It is considered that minority variants under specific selective pressure may become predominant and provide a fitness advantage, ultimately influencing the epidemic, as seems to have occurred with the D614G mutation.
Discussion: Similarly, in our study, except for D614G, no mutation or minority variants were observed in the S gene coding for the spike protein; most were observed within the ORF1ab gene, which encodes the replication complex responsible for RNA synthesis.|


  Rapid Detection and Inhibition of SARS-CoV-2-Spike Mutation-Mediated Microthrombosis.
 PMID: 34687279       2021       Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Result: Fibrin surface coverage for Lipo-S was 9.53% +- 1.46% (**p < 0.01 vs control, n = 4), similarly to the Lenti-S variant D614G which also promoted significant fibrin deposition surface coverage at 9.56% +- 3.23% (**p < 0.01 vs control, n = 4) (Figure 2a,b).
Result: Furthermore, anti-IL-6 staining was prominent in Lenti-S D614G transduced HAECs (Figure 3c).
Result: Lenti-S D614G exposure upregulated cytokines (e.g., TNF-alpha, IL-6, and IL-15) and chemokines (e.g., MCP1), together with aberrantly elevated level of endothelial markers, such as v


  Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients.
 PMID: 34688034       2021       EBioMedicine
Discussion: The least negative impact on neutralization was seen for Iota variant, which is reasonable since this isolate has very few changes in the spike protein (T95I, D253G and D614G) compared to the wild type WA1 isolate.


  Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner.
 PMID: 34688376       2021       Cell host & microbe
Figure: (A) Neutralization of the SARS-CoV-2 D614G pseudovirus by plasma pre- and post-vaccination from participants with no prior infection (green, n = 19) and those infected in the first (blue, n = 20) and second waves (red, n = 19).
Figure: (B) Cross-reactive ADCC activity 28 days post-vaccina
Discussion: However, although Beta infection resulted in the preserved neutralization of D614G, we, like others, noted significant loss of activity against Delta.


  Emerging SARS-CoV-2 variants expand species tropism to murines.
 PMID: 34689086       2021       EBioMedicine
Result: Our results showed that permissibility to mouse cells was not due to the D614G mutation as B.1 did not replicate in the nasal turbinate and lung of the inoculated mice.
Result: Since B.1.1.7, B.1.351, and P.3 all shares both the D614G and N501Y mutation in spike, we included B.1 as a control virus, which carries the D614G but not the N501Y mutation, to exclude the possibility that D614G conferred infectivity to mice.


  Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617.
 PMID: 34691002       2021       Frontiers in microbiology
Introduction: Some of the aa changes or similar ones in B.1.617 were also identified in other circulating lineages: D614G was also found in B.1 lineage, L452R in B.1.526 (Iota), and P681H in B.1.1.7 (Alpha).
Introduction: Though the amino acid (aa) changes of G142D, L452R, D614G, and P681R occurring in the
Result: We found that the B.1.617 viruses and H1 were distinguished by four non-synonymous mutations: U1355G (L452R), G1450C (E484Q), A1841G (D614G), and C2042G (P681R).


  Genomic epidemiology and the role of international and regional travel in the SARS-CoV-2 epidemic in Zimbabwe: a retrospective study of routinely collected surveillance data.
 PMID: 34695371       2021       The Lancet. Global health
Abstract: 151 (97%) of 156 had the Asp614Gly mutation in the spike protein.
Result: 151 (97%) of 156 samples contained the Asp614Gly mutation.
Result: We established the distribution and frequency of the Asp614Gly variant in SARS-CoV-2 genomes from Zimbabwe.



Browser Board

 Co-occurred Entities




   Filtrator